Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Application of Hematopoietic Progenitor Cell Count: To Optimize Peripheral Blood Stem Cell Harvest

Masataka Takeshita, MD PhD, Risen Hirai, MD, Akira Tanimura, MD, Miki Nakamura, MD PhD, Shotaro Hagiwara, MD PhD, Akiyoshi Miwa, MD PhD

Blood (2014) 124 (21): 5837.

https://doi.org/10.1182/blood.V124.21.5837.5837

Published: 2014

Journal Articles

Role Of Double Stem Cell Transplantation For Newly Diagnosed Multiple Myeloma In The Era Of Novel Agents

Shotaro Hagiwara, MD, PhD, Risen Hirai, MD, Miki Nakamura, MD, PhD, Akira Tanimura, MD, Masataka Takeshita, MD, PhD, Akiyoshi Miwa, MD, PhD

Blood (2013) 122 (21): 2171.

https://doi.org/10.1182/blood.V122.21.2171.2171

Published: 2013

Journal Articles

The Spectrum Of Pathological Findings Of Kidney Injury In The Cases Of Multiple Myeloma: A Clinico-Pathological Study Of 93 Consecutive Autopsy Cases

Sohtaro Mine, MD, Shotaro Hagiwara, MD, PhD, Risen Hirai, MD, Akira Tanimura, MD, Miki Nakamura, MD, PhD, Masataka Takeshita, MD, PhD, Akiyoshi Miwa, MD, PhD, Toru Igari, MD PhD

Blood (2013) 122 (21): 5321.

https://doi.org/10.1182/blood.V122.21.5321.5321

Published: 2013

Journal Articles

What Is the Appropriate Dose Attenuation System of RCHOP for Elderly DLBCL Patients? - A Single Institutional Analysis in 115 Cosecutive Patients From Japan -

Akira Tanimura, MD, Risen Hirai, MD, Atsushi Sato, MD, Miki Nakamura, MD, PhD, Masataka Takeshita, MD, PhD, Shotaro Hagiwara, MD, PhD, Akiyoshi Miwa, MD

Blood (2012) 120 (21): 3639.

https://doi.org/10.1182/blood.V120.21.3639.3639

Published: 2012

Journal Articles

High-Dose Cyclophosphamide + G-CSF Mobilization Regimen Have Higher Anti-Myeloma Effects Than G-CSF Alone Regimen – Single Institutional Study in 147 Myeloma Patients From Japan

Akira Tanimura, MD, Masataka Takeshita, MD, PhD, Atsushi Sato, MD, Junichiro Takano, MD, Hideaki Kitahara, MD, Ayato Tsukamoto, MD, Yuko Kimura, MD, Risen Hirai, MD, Miki Nakamura, MD, PhD, Shotaro Hagiwara, MD, PhD, Mineo Kurokawa, MD, PhD, Akiyoshi Miwa, MD

Blood (2011) 118 (21): 2007.

https://doi.org/10.1182/blood.V118.21.2007.2007

Published: 2011

Journal Articles

CD125-Expressing Myeloma: A Subgroup of Multiple Myeloma (MM) with Immature Phenotype, Endoplasmic Reticulum Stress Response and Low Sensitivity to Bortezomib

Yawara Kawano, Yoshitaka Kikukawa, Miki Nakamura, Yutaka Okuno, MD, PhD, Hiromichi Yuki, Shiho Fujiwara, Hiroaki Mitsuya, Hiroyuki Hata, MD, PhD

Blood (2010) 116 (21): 616.

https://doi.org/10.1182/blood.V116.21.616.616

Published: 2010

Journal Articles

Acute Promyelocytic Leukemia Harboring STAT5b-RAR α Fusion Gene and G596V Mutation in the Stat5b SH2 Domain of the Fusion Gene.

Eisaku Iwanaga, Miki Nakamura, Tomoko Nanri, Toshiro Kawakita, Naofumi Matsuno, Koyu Hoshino, Kentaro Horikawa, Hiroaki Mitsuya, Norio Asou

Blood (2007) 110 (11): 4227.

https://doi.org/10.1182/blood.V110.11.4227.4227

Published: 2007

Journal Articles

Clarithromicin Induces Autophagy in Myeloma Cells.

Miki Nakamura, MD, PhD, Takahiro Kamimoto, PhD, Tamotsu Yoshimori, PhD, Hiroaki Mitsuya, MD PhD, Hiroyuki Hata, MD PhD

Blood (2006) 108 (11): 3509.

https://doi.org/10.1182/blood.V108.11.3509.3509

Published: 2006

Journal Articles

Kigamicin Induces Necrosis to Human Myeloma Cells by Disruption of Cell Cycle Regulation.

Miki Nakamura, MD, PhD, Hiroyasu Esumi, MD PhD, Jie Lu, PhD, Hiroaki Mitsuya, MD PhD, Hiroyuki Hata, MD PhD

Blood (2006) 108 (11): 5017.

https://doi.org/10.1182/blood.V108.11.5017.5017

Published: 2006

Journal Articles

Induction of Autophagy to Myeloma Cells by Thalidomide and Clarithromycin.

Miki Nakamura, Takahiro Kamimoto, Tamotsu Yoshimori, Yutaka Okuno, Motohiro Takeya, Hiroaki Mitsuya, Hiroyuki Hata

Blood (2005) 106 (11): 5134.

https://doi.org/10.1182/blood.V106.11.5134.5134

Published: 2005

NARROW

Application of Hematopoietic Progenitor Cell Count: To Optimize Peripheral Blood Stem Cell Harvest

Role Of Double Stem Cell Transplantation For Newly Diagnosed Multiple Myeloma In The Era Of Novel Agents

The Spectrum Of Pathological Findings Of Kidney Injury In The Cases Of Multiple Myeloma: A Clinico-Pathological Study Of 93 Consecutive Autopsy Cases

What Is the Appropriate Dose Attenuation System of RCHOP for Elderly DLBCL Patients? - A Single Institutional Analysis in 115 Cosecutive Patients From Japan -

High-Dose Cyclophosphamide + G-CSF Mobilization Regimen Have Higher Anti-Myeloma Effects Than G-CSF Alone Regimen – Single Institutional Study in 147 Myeloma Patients From Japan

CD125-Expressing Myeloma: A Subgroup of Multiple Myeloma (MM) with Immature Phenotype, Endoplasmic Reticulum Stress Response and Low Sensitivity to Bortezomib

Acute Promyelocytic Leukemia Harboring STAT5b-RAR α Fusion Gene and G596V Mutation in the Stat5b SH2 Domain of the Fusion Gene.

Clarithromicin Induces Autophagy in Myeloma Cells.

Kigamicin Induces Necrosis to Human Myeloma Cells by Disruption of Cell Cycle Regulation.

Induction of Autophagy to Myeloma Cells by Thalidomide and Clarithromycin.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only